国邦医药:累计回购公司股份5375274股
Group 1 - The core announcement is that Guobang Pharmaceutical has repurchased a total of 5,375,274 shares through centralized bidding as of July 31, 2025, which represents 0.96% of the company's total share capital [2]
Group 1 - The core announcement is that Guobang Pharmaceutical has repurchased a total of 5,375,274 shares through centralized bidding as of July 31, 2025, which represents 0.96% of the company's total share capital [2]